| Value | ₹198.0 Cr |
|---|
NSE filing, NSE: MEDIASSIST. Summary written from the filing by ALFA Finder's alert engine.
Medi Assist Healthcare Services Ltd: key numbers
- Share price
- ₹295.20
- Market cap
- ₹2,205 Cr
- Revenue (annual)
- ₹904.8 Cr
- Net profit (annual)
- ₹87.89 Cr
- P/E (TTM)
- 23.6×Sector 52.8×
- Promoter holding
- 4.61%+0.00% QoQ
- FII holding
- 24.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medi Assist Healthcare Services Ltd
All →Medi Assist Healthcare Services Results Update
Medi Assist reported H1 FY27 results with higher revenue, EBITDA and profit year-on-year. It also announced a board-approved share buyback.
Medi Assist Healthcare Services Investor Presentation: Key Takeaways
Q2FY27 operating revenue ₹241.5 Cr (+3.9%), EBITDA ₹49.2 Cr (+23.9%), margin 20.4% (+331 bps). H1 revenue ₹478.0 Cr (+13.0%); Paramount integration complete.
Medi Assist Healthcare Services Other Announcement
Medi Assist filed its Reg 32 statement for the quarter ended September 30, 2026, reporting no deviation in use of preferential issue proceeds. CARE Ratings' monitoring agency report is enclosed.
Medi Assist Healthcare Services Capital Structure Change
Medi Assist Healthcare's board approved a tender-offer buyback of up to 11,59,199 shares at Rs 425 each, capped at Rs 49.27 Crore. The record date is 20 November 2026, and promoters will not participate.
- Value
- ₹49.27 Cr
Medi Assist Healthcare Services Q2 FY27 Results: Net Profit ₹21.6 Cr, Up 166.7% YoY
Medi Assist Healthcare Services Ltd reported revenue from operations of ₹241.5 Cr (+3.9% YoY) and net profit of ₹21.6 Cr (+166.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹21.6 Cr · +166.7% YoY
Medi Assist Healthcare Services Board Meeting Date
Medi Assist Healthcare Services intimated a board meeting on 30 October 2026 to consider unaudited quarterly results and a proposed share buyback. The trading window is closed from 1 October to 1 November 2026.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.